Jaguar Health company information, Employees & Contact Information

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Las Cruces Sun-News

Will Jaguar Health Inc. stock pay special dividends - Rate Cut & Low Risk Growth Stock Ideas newser.com

Will Jaguar Health Inc. benefit from macro trends - July 2025 Big Picture & Weekly Market Pulse Updates newser.com

Will Jaguar Health Inc. benefit from macro trends - 2025 Volatility Report & Fast Exit and Entry Trade Guides newser.com

Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders Corpus Christi Caller-Times

FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease Morris County NJ News | Daily Record

Can Jaguar Health Inc. stock surprise with earnings upside - 2025 Big Picture & Capital Protection Trade Alerts Fundação Cultural do Pará

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Asbury Park Press

FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease Green Bay Press-Gazette

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) The News-Press

Jaguar Health (NASDAQ:JAGX) grants RSUs to 3 new hires under Rule 5635(c)(4) Stock Titan

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Kansas City Star

How to use Fibonacci retracement on Jaguar Health Inc. - 2025 Retail Activity & Accurate Buy Signal Notifications newser.com

Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts The Daily Jeffersonian

FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease Lancaster Eagle-Gazette

Will Jaguar Health Inc. stock pay special dividends - Market Performance Report & Reliable Entry Point Alerts newser.com

Will Jaguar Health Inc. benefit from macro trends - Earnings Recap Summary & Daily Entry Point Alerts newser.com

Can Jaguar Health Inc. stock surprise with earnings upside - July 2025 WrapUp & Daily Entry Point Trade Alerts newser.com

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ACCESS Newswire

Death Cross: Why Jaguar Health Inc. stock attracts high net worth investors - July 2025 Price Swings & Accurate Entry/Exit Alerts Trung tâm Dự báo KTTV quốc gia

Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID) Pueblo Chieftain

Analyst Upgrade: Why Jaguar Health Inc. stock attracts high net worth investors - Weekly Stock Report & AI Forecasted Stock Moves Trung tâm Dự báo KTTV quốc gia

Will Jaguar Health Inc. stock pay special dividends - Trade Volume Report & Daily Oversold Stock Bounce Ideas newser.com

Why Jaguar Health Inc. stock attracts high net worth investors - Treasury Yields & Comprehensive Market Scan Reports Trung tâm Dự báo KTTV quốc gia

Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts Tallahassee Democrat

Downgrade Watch: Why Jaguar Health Inc. stock remains a top recommendation - July 2025 Gainers & Reliable Entry Point Trade Alerts Trung tâm Dự báo KTTV quốc gia

Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts Waynesboro Record Herald

Will Jaguar Health Inc. benefit from macro trends - Weekly Profit Report & High Return Trade Guides newser.com

Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition Peoria Journal Star

Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID) The Marion Star

Published on: 2025-10-20 23:42:24 Trung tâm Dự báo KTTV quốc gia

FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease The Asheville Citizen Times

Will Jaguar Health Inc. benefit from macro trends - July 2025 PostEarnings & Risk Managed Investment Entry Signals newser.com

Can Jaguar Health Inc. stock surprise with earnings upside - Market Activity Report & Stepwise Entry and Exit Trade Signals newser.com

FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease The Herald-Mail

Can Jaguar Health Inc. stock surprise with earnings upside - July 2025 EndofMonth & Trade Opportunity Analysis Reports newser.com

Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease (MVID) Yahoo Finance

How Jaguar Health Inc. stock performs during Fed tightening cycles - July 2025 Catalysts & Consistent Profit Trade Alerts Trung tâm Dự báo KTTV quốc gia

Price action breakdown for Jaguar Health Inc. - Market Volume Report & Free Weekly Chart Analysis and Trade Guides newser.com

Published on: 2025-10-18 20:25:58 Trung tâm Dự báo KTTV quốc gia

FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease USA Today

Is Jaguar Health Inc. stock a buy before product launches - July 2025 Retail & Consistent Profit Trading Strategies Trung tâm Dự báo KTTV quốc gia

Will Jaguar Health Inc. stock pay special dividends - 2025 Investor Takeaways & Expert Approved Trade Ideas newser.com

Will Jaguar Health Inc. stock pay special dividends - Trade Entry Summary & Long-Term Safe Return Strategies newser.com

Will Jaguar Health Inc. benefit from macro trends - July 2025 Technicals & High Accuracy Trade Signal Alerts newser.com

Can Jaguar Health Inc. stock surprise with earnings upside - Trade Analysis Summary & Weekly Stock Breakout Alerts newser.com

Why Jaguar Health Inc. stock remains a top recommendation - Quarterly Portfolio Report & Free Reliable Trade Execution Plans Trung tâm Dự báo KTTV quốc gia

Will Jaguar Health Inc. (1JA0) stock beat international competition - Dip Buying & Free Community Consensus Stock Picks Trung tâm Dự báo KTTV quốc gia

Why Jaguar Health Inc. stock remains a top recommendation - July 2025 PostEarnings & Capital Protection Trading Alerts Trung tâm Dự báo KTTV quốc gia

Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition Erie Times-News

Can Jaguar Health Inc. stock surprise with earnings upside - Stop Loss & Stock Portfolio Risk Control newser.com

Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease (MVID) The Newark Advocate

37% PS reduction; Jaguar Health's crofelemer powder reduced TPN 30% in pediatric MVID trial Stock Titan

Biotech Leader Jaguar Health Sets Dual Conference Appearances: Key Updates Coming at September Events Stock Titan

Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease (MVID) Cape Cod Times

Published on: 2025-10-21 08:41:05 Trung tâm Dự báo KTTV quốc gia

Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts Ashland Times-Gazette

Will Jaguar Health Inc. outperform the market - 2025 Market Sentiment & Short-Term High Return Ideas newser.com

Can Jaguar Health Inc. stock surprise with earnings upside - Trade Performance Summary & Precise Buy Zone Tips newser.com

Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease (MVID) BlueRidgeNow.com

Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease (MVID) Daytona Beach News-Journal

Tools to assess Jaguar Health Inc.’s risk profile - Quarterly Portfolio Report & AI Powered Market Entry Strategies newser.com

Is Jaguar Health Inc. stock a buy before product launches - Volume Spike & Free Technical Pattern Based Buy Signals Trung tâm Dự báo KTTV quốc gia

Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts Lansing State Journal

Earnings call transcript: Jaguar Health Q2 2025 sees revenue boost, stock tumbles Investing.com

Will Jaguar Health Inc. benefit from macro trends - Weekly Risk Report & Weekly Top Gainers Trade List newser.com

Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules Yahoo Finance

Is now a turning point for Jaguar Health Inc. - Weekly Risk Report & Reliable Volume Spike Alerts newser.com

Can Jaguar Health Inc. stock surprise with earnings upside - July 2025 Review & Reliable Momentum Entry Alerts newser.com

Jaguar Health, Inc. Announces Reverse Stock Split Yahoo Finance

Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Yahoo Finance

Tools to assess Jaguar Health Inc.’s risk profile - July 2025 Decliners & Real-Time Market Sentiment Alerts newser.com

Jaguar Health provides drug for expanded access to treat rare disease Investing.com

Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts Yahoo Finance

27% TPN Reduction: Jaguar Health's Crofelemer Shows Promise in Ultra-Rare MVID Disease Treatment Stock Titan

Jaguar Health Provides Overview of 2025 Crofelemer-Related Catalysts Yahoo Finance

Jaguar Health Announces Double Header: Q2 Earnings Call and Emerging Growth Conference Presentation This Week Stock Titan

Jaguar Health Inc (JAGX) Q1 2025 Earnings Call Highlights: Navigating Challenges with Promising ... Yahoo Finance

Slammed 27% Jaguar Health, Inc. (NASDAQ:JAGX) Screens Well Here But There Might Be A Catch simplywall.st

Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue Yahoo Finance

Why Jaguar Health Inc. stock remains a top recommendation - Weekly Loss Report & Daily Momentum Trading Reports newser.com

Proof-of-Concept Results Show Jaguar Health's Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient Yahoo Finance

Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts Barnstable Patriot

Jaguar Health receives $250,000 FDA grant for canine diarrhea drug study Investing.com

Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates Yahoo Finance

Novel Diarrhea Drug Could Help Breast Cancer Patients: Jaguar Health Pursues Special FDA Status Stock Titan

Jaguar Health Receives Notice of $250,000 FDA Grant to Fund Confirmatory Trial to Support FDA Approval of Canalevia for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs Yahoo Finance

Jaguar Health Reports 2024 Financials: 2024 Net Revenue Up Approximately 20% Over 2023 Yahoo Finance

Jaguar Health Participating in August 25-26 Animal Health Summit with Goal of Securing Collaboration to Expand Canalevia's Indication to Treatment of General Diarrhea in Dogs Yahoo Finance

Jaguar Health Reports Increased Losses Amid Rising Expenses TipRanks

Jaguar Health Adopts Limited Duration Stockholder Rights Plan to Ensure Stockholders Can Realize Long-Term Value Yahoo Finance

Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition Yahoo Finance

27% TPN Reduction: Jaguar Health's Crofelemer Shows Promise in MVID Trial Ahead of FDA Strategy Stock Titan

Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs Yahoo Finance

Jaguar Health CEO Reveals Near-Term Catalysts at Emerging Growth Conference Tomorrow Stock Titan

Jaguar Health (JAGX) Advances Crofelemer Trial Following FDA Mee GuruFocus

Jaguar Health reports positive results in MVID treatment trial Investing.com

Biotech Pioneer Jaguar Health Embraces Crypto: Board Approves Bitcoin Treasury Strategy Stock Titan

Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition GoUpstate

Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition The Newark Advocate